Overview

Pentoxifylline Treatment in Acute Pancreatitis (AP)

Status:
Completed
Trial end date:
2017-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis.
Phase:
Phase 3
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Pentoxifylline